Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Oct;68(4):712–714. doi: 10.1038/bjc.1993.415

Exclusion of constitutional p53 mutations as a cause of genetic susceptibility to colorectal cancer.

T Bhagirath 1, A Condie 1, M G Dunlop 1, A H Wyllie 1, J Prosser 1
PMCID: PMC1968627  PMID: 8398698

Full text

PDF
712

Images in this article

712Figure 1
on p.712

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinger A. C., Jessup J. M., vanTuinen P., Ledbetter D. H., Barker D. F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989 Apr 14;244(4901):217–221. doi: 10.1126/science.2649981. [DOI] [PubMed] [Google Scholar]
  2. Bishop D. T., Thomas H. J. The genetics of colorectal cancer. Cancer Surv. 1990;9(4):585–604. [PubMed] [Google Scholar]
  3. Burt R. W., Bishop D. T., Cannon-Albright L., Samowitz W. S., Lee R. L., DiSario J. A., Skolnick M. H. Hereditary aspects of colorectal adenomas. Cancer. 1992 Sep 1;70(5 Suppl):1296–1299. doi: 10.1002/1097-0142(19920901)70:3+<1296::aid-cncr2820701516>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  4. Bülow S. Familial polyposis coli. Dan Med Bull. 1987 Mar;34(1):1–15. [PubMed] [Google Scholar]
  5. Caron de Fromentel C., Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer. 1992 Jan;4(1):1–15. doi: 10.1002/gcc.2870040102. [DOI] [PubMed] [Google Scholar]
  6. Condie A., Eeles R., Borresen A. L., Coles C., Cooper C., Prosser J. Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Hum Mutat. 1993;2(1):58–66. doi: 10.1002/humu.1380020111. [DOI] [PubMed] [Google Scholar]
  7. Cotton R. G., Rodrigues N. R., Campbell R. D. Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4397–4401. doi: 10.1073/pnas.85.12.4397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dunlop M. G. Colorectal cancer genetics. Semin Cancer Biol. 1992 Jun;3(3):131–140. [PubMed] [Google Scholar]
  9. Fearon E. R., Cho K. R., Nigro J. M., Kern S. E., Simons J. W., Ruppert J. M., Hamilton S. R., Preisinger A. C., Thomas G., Kinzler K. W. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990 Jan 5;247(4938):49–56. doi: 10.1126/science.2294591. [DOI] [PubMed] [Google Scholar]
  10. Groden J., Gelbert L., Thliveris A., Nelson L., Robertson M., Joslyn G., Samowitz W., Spirio L., Carlson M., Burt R. Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals. Am J Hum Genet. 1993 Feb;52(2):263–272. [PMC free article] [PubMed] [Google Scholar]
  11. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 1991 Jul 5;253(5015):49–53. doi: 10.1126/science.1905840. [DOI] [PubMed] [Google Scholar]
  12. Kinzler K. W., Nilbert M. C., Su L. K., Vogelstein B., Bryan T. M., Levy D. B., Smith K. J., Preisinger A. C., Hedge P., McKechnie D. Identification of FAP locus genes from chromosome 5q21. Science. 1991 Aug 9;253(5020):661–665. doi: 10.1126/science.1651562. [DOI] [PubMed] [Google Scholar]
  13. Law J. C., Strong L. C., Chidambaram A., Ferrell R. E. A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res. 1991 Dec 1;51(23 Pt 1):6385–6387. [PubMed] [Google Scholar]
  14. Li F. P., Fraumeni J. F., Jr Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969 Oct;71(4):747–752. doi: 10.7326/0003-4819-71-4-747. [DOI] [PubMed] [Google Scholar]
  15. Lynch H. T., Kimberling W., Albano W. A., Lynch J. F., Biscone K., Schuelke G. S., Sandberg A. A., Lipkin M., Deschner E. E., Mikol Y. B. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer. 1985 Aug 15;56(4):934–938. doi: 10.1002/1097-0142(19850815)56:4<934::aid-cncr2820560439>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  16. Lynch H. T., Schuelke G. S., Kimberling W. J., Albano W. A., Lynch J. F., Biscone K. A., Lipkin M. L., Deschner E. E., Mikol Y. B., Sandberg A. A. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer. 1985 Aug 15;56(4):939–951. doi: 10.1002/1097-0142(19850815)56:4<939::aid-cncr2820560440>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  17. Lynch H. T., Watson P., Kriegler M., Lynch J. F., Lanspa S. J., Marcus J., Smyrk T., Fitzgibbons R. J., Jr, Cristofaro G. Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II). Dis Colon Rectum. 1988 May;31(5):372–377. doi: 10.1007/BF02564888. [DOI] [PubMed] [Google Scholar]
  18. Lynch H. T., Watson P., Smyrk T. C., Lanspa S. J., Boman B. M., Boland C. R., Lynch J. F., Cavalieri R. J., Leppert M., White R. Colon cancer genetics. Cancer. 1992 Sep 1;70(5 Suppl):1300–1312. doi: 10.1002/1097-0142(19920901)70:3+<1300::aid-cncr2820701517>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  19. Malkin D., Jolly K. W., Barbier N., Look A. T., Friend S. H., Gebhardt M. C., Andersen T. I., Børresen A. L., Li F. P., Garber J. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992 May 14;326(20):1309–1315. doi: 10.1056/NEJM199205143262002. [DOI] [PubMed] [Google Scholar]
  20. Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Jr, Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990 Nov 30;250(4985):1233–1238. doi: 10.1126/science.1978757. [DOI] [PubMed] [Google Scholar]
  21. Mecklin J. P. Frequency of hereditary colorectal carcinoma. Gastroenterology. 1987 Nov;93(5):1021–1025. doi: 10.1016/0016-5085(87)90565-8. [DOI] [PubMed] [Google Scholar]
  22. Nagase H., Miyoshi Y., Horii A., Aoki T., Petersen G. M., Vogelstein B., Maher E., Ogawa M., Maruyama M., Utsunomiya J. Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Hum Mutat. 1992;1(6):467–473. doi: 10.1002/humu.1380010603. [DOI] [PubMed] [Google Scholar]
  23. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991 Aug 9;253(5020):665–669. doi: 10.1126/science.1651563. [DOI] [PubMed] [Google Scholar]
  24. Peltomäki P., Sistonen P., Mecklin J. P., Pylkkänen L., Järvinen H., Simons J. W., Cho K. R., Vogelstein B., de la Chapelle A. Evidence supporting exclusion of the DCC gene and a portion of chromosome 18q as the locus for susceptibility to hereditary nonpolyposis colorectal carcinoma in five kindreds. Cancer Res. 1991 Aug 15;51(16):4135–4140. [PubMed] [Google Scholar]
  25. Prosser J., Elder P. A., Condie A., MacFadyen I., Steel C. M., Evans H. J. Mutations in p53 do not account for heritable breast cancer: a study in five affected families. Br J Cancer. 1991 Feb;63(2):181–184. doi: 10.1038/bjc.1991.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Prosser J., Porter D., Coles C., Condie A., Thompson A. M., Chetty U., Steel C. M., Evans H. J. Constitutional p53 mutation in a non-Li-Fraumeni cancer family. Br J Cancer. 1992 Apr;65(4):527–528. doi: 10.1038/bjc.1992.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Prosser J., Thompson A. M., Cranston G., Evans H. J. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene. 1990 Oct;5(10):1573–1579. [PubMed] [Google Scholar]
  28. Srivastava S., Zou Z. Q., Pirollo K., Blattner W., Chang E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990 Dec 20;348(6303):747–749. doi: 10.1038/348747a0. [DOI] [PubMed] [Google Scholar]
  29. Toguchida J., Yamaguchi T., Dayton S. H., Beauchamp R. L., Herrera G. E., Ishizaki K., Yamamuro T., Meyers P. A., Little J. B., Sasaki M. S. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med. 1992 May 14;326(20):1301–1308. doi: 10.1056/NEJM199205143262001. [DOI] [PubMed] [Google Scholar]
  30. de la Calle-Martín O., Fabregat V., Romero M., Soler J., Vives J., Yagüe J. AccII polymorphism of the p53 gene. Nucleic Acids Res. 1990 Aug 25;18(16):4963–4963. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES